Noted anthropologist Stefan Helmreich will provide insights on how scientists are studying waves in nature to understand phenomena as diverse as the social sciences and climate change.
Sepsis, an over-the-top immune system response to an infection, is a common and costly cause of death and the most expensive condition treated in U.S. hospitals. The NIH grant will support research collaborations that may pave the way for new treatment targets.
For most of us, life without a smartphone is unimaginable. Now, picture your smartphone without the pioneering federally funded research done at America’s research universities. You can’t, because your smartphone would not exist without that research.
Elika Bergelson, a newly-appointed research assistant professor in the Department of Brain and Cognitive Sciences, focuses on understanding how babies learn words between 6-to 18-months old. Funding from the NIH recognizes Bergelson as one of the nation’s “exceptional early career scientist” and will help her pathbreaking work advance more quickly.
Given the widespread attention regarding the current Ebola outbreak in West Africa, four Medical Center faculty with expertise in viral infections field questions about the outbreak, the nature of pandemics, vaccines, and what a U.S. outbreak might look like.
More than $6 million in funding from the National Institute of Mental Health is supporting new research led by Rochester’s Center for Translational Neuromedicine that could fundamentally alter the way we comprehend and, perhaps ultimately, treat schizophrenia.
The National Institutes of Health has invited the Medical Center to join the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network. Made up of 11 research groups from around the country, its aim is to develop new treatments for patients with the conditions.
Scientists have recently developed several ways—some simple and some involving new technologies—to hide objects from view. The latest effort, developed by physics professor John Howell and graduate student Joseph Choi, not only overcomes some limitations of previous devices, but uses inexpensive, readily available materials in a new way. “This is the first device that we know of that can do three-dimensional, continuously multidirectional cloaking,” said Choi.
UR Ventures has awarded three new Technology Development Fund (TDF) grants to projects in the fields of infectious disease, diabetes, and neuromedicine. Paul Dunman, Ph.D., with the Department of Microbiology and Immunology, was awarded $99,000 for his project, “Prevention and Treatment of MRSA Infections.” Dunman and his colleagues have discovered a novel compound to treat […]